Citadel Advisors - PHARMATHENE INC ownership

PHARMATHENE INC's ticker is and the CUSIP is 71714G952. A total of 2 filers reported holding PHARMATHENE INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PHARMATHENE INC
ValueSharesWeighting
Q2 2016$30,000
-28.6%
12,100
-45.7%
0.00%
Q1 2016$42,000
+200.0%
22,300
+193.4%
0.00%
Q4 2014$14,000
-41.7%
7,600
-44.5%
0.00%
Q3 2014$24,000
+166.7%
13,700
+110.8%
0.00%
Q2 2014$9,000
+200.0%
6,500
+364.3%
0.00%
Q1 2014$3,0000.0%1,400
-36.4%
0.00%
Q2 2013$3,0002,2000.00%
Other shareholders
PHARMATHENE INC shareholders Q4 2014
NameSharesValueWeighting ↓
Citadel Advisors 7,600$14,0000.00%
GROUP ONE TRADING, L.P. 15,900$29,0000.00%
View complete list of PHARMATHENE INC shareholders